LABNEW (LAB) 24-Hour Volatility at 50.8%: Whale Accumulation Drives High Trading Volume Rebound Amid Large Supply Transfer Risk
Bitget Pulse2026/05/13 16:02Volatility Overview
In the past 24 hours, the price of LABNEW (LAB) rebounded from a low of $4.35249 to a high of $6.56148, currently quoted at $5.82146, with a price fluctuation range of 50.8%. The 24-hour trading volume stayed within the $55 million to $60 million range, with on-chain data showing a clear sign of net capital inflow.
Analysis of Abnormal Movements
- Continued accumulation by whale addresses: On-chain monitoring indicates that large buyers drove the price rebound from the lows, accompanied by increased trading volume.
- Recent large transfers: On May 12, approximately 100 million LAB (accounting for 32% of circulating supply) were transferred from Bitget exchange to 10 newly created wallets, valued at around $480 million. This move directly triggered a pullback in price from the May 11 ATH of $6.66.
Market Views and Outlook
Market sentiment is relatively cautious. On-chain analysts interpret the recent transfers as distribution rather than accumulation; mainstream opinions warn about potential selling pressure, and technical analysis predicts a downside target at the $2.54 support level. The community is closely watching whale activity, and short-term rebound momentum may be weakened by supply unlocks.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Nebius Q3 results exceed expectations, capital expenditure rises to $27 billion, ARR target postponed, stock falls over 14% pre-market | Earnings Report Insights
Nebius reported Q3 revenue of $981 million (a year-on-year increase of 571%) and adjusted EBITDA of $466 million, both exceeding expectations. However, the company delayed and lowered its guidance for annual recurring revenue (ARR), stating that it is no longer applicable. Additionally, it significantly raised its 2026 capital expenditure target to $27 billion, with projections to further increase to $40 billion to $45 billion in 2027. The stock price plummeted more than 14% in pre-market trading.